Products
OEM Manufacturer Thyroid Tumor Marker - Lumilite 8 POCT CLIA System – Illumaxbio
OEM Manufacturer Thyroid Tumor Marker - Lumilite 8 POCT CLIA System – Illumaxbio Detail:
Description
Lumilite 8 is a 25cm, easy to use, bench-top chemiluminescent immunoassay analyzer providing affordable, core-lab quality results from whole blood/serum/plasma samples in under 15 minutes. A broad menu of tests to support better differentiation from a single sample, on a single run, on a single instrument.
With the flexibility to run up to 8 tests simultaneously, and self-developed bead separation system & intelligent single photon counting module, Lumilite 8 ensures highly accurate and precision results (CV≤5%).
With Only 12kg and 3-step operation, Lumilite 8 provides easy to use point-of-care solutions outside the core lab, providing immediate results and thus allowing treatment decisions to be made more quickly – inside or outside the hospital.
Product Features
1.Sample types: run whole blood/plasma/serum samples, no sample preparation, no manual dilutions.
2.Rapid turnaround time: It can run 8 simultaneous tests in under 15 minutes, and up to 32 tests per hour.
3.Flexibility : perform any of the assays – from 1 to 8 tests per run.
4.Broad menu: over 100 parameters available in single-test ready-to-use format.
5.Light weight: only 12kg.
6.On-demand testing: 1 patient, 1 test, 1 result, ready-to-use reagents.
7.Cost effective: no liquid, no consumable, no carryover, minimum maintenance.
Specifications
| Measuring principle | Chemiluminescence enzyme immunoassay technology (CLIA) |
| Throughput | 32 T/H |
| Sample type | whole blood/ serum/ plasma |
| Reaction temperature | 37℃ |
| Display | 8′ touch screen |
| Electrical requirements | AC100-240V |
| Reagent scanner | Intergrated |
| Sample scanner | Intergrated |
| Thermal printer | Intergrated |
| Interface | USB*2、RJ45 |
| Dimension(W*D*H) | 228*385*256mm |
| Weight | 12kg |
Product Description
The POCT CLIA System lumilite 8 is a quantitative and accurate immunoassay analysis system. It utilizes the ALP enzymatic cheminluminescence system which is easy to operate and fast to measure. It adopts self-developed versatile magnetic bead separation technology and intelligent single photon counting module to minimize interference and greatly improves the precision of detection.
Product Application
Lumilite 8 is only cola height with precision results, so it is widely used in ambulances, cardiology, emergency, CPC, ICU, clinic, , field troops…
Product Details
01
SDI
Software define immunoassay
Handle complicated workflow easily
Better adaptability than tranditional CLIA system
02
VBS
Versatile bead separation
Automatic Pierce
Precise sample adding
Efficient bead separation
Magnetic beads mixing
03
AOI
Automatic optical inspection
Identify anomalies through the AI visual to guarantee the reliability of system
04
OTA
Over the air
Remote maintenance and upgrade
05
ISPCM
Intelligent single photon counting module
06
Technology
Develpoed with newest technology
Wide linear
Low noise
Integrated Shutter
Built-in correction algorithm
Product detail pictures:
Related Product Guide:
We thinks what clients think, the urgency of urgency to act from the interests of a client position of theory, allowing for greater quality, lessen processing costs, price ranges are much more reasonable, won the new and outdated shoppers the support and affirmation for OEM Manufacturer Thyroid Tumor Marker - Lumilite 8 POCT CLIA System – Illumaxbio , The product will supply to all over the world, such as: Swaziland, Porto, Slovakia, Our products are sold to the Middle East, Southeast Asia, Africa, Europe, America and other regions, and are favorably appraised by clients. To benefit from our strong OEM/ODM capabilities and considerate services, please contact us today. We will sincerely create and share success with all clients.
By Ellen from Porto - 2017.04.18 16:45
Customer service staff and sales man are very patience and they all good at English, product's arrival is also very timely, a good supplier.
By Honey from Belgium - 2018.06.21 17:11
